CD38 and neoplasm: Based on the above-reported evidence, it can be stated that CD38 exerts a protumorigenic role, both through its enzymatic activity and its receptor functions, by activating downstream pathways in tumor cells that enhance their proliferative, antiapoptotic and migratory ability, and promoting immune evasion through the recruitment of immunosuppressive cells and T-cell exhaustion.